Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity.
Embryonic stem cells offer unprecedented opportunities for random or targeted genome alterations in the mouse. We present here an efficient strategy to create chromosome-specific loss of heterozygosity in embryonic stem cells. The combination of this method with genome-wide mutagenesis in ES cells (using chemical mutagens or gene-trap vectors) opens up the possibility for in vitro or in vivo functional screening of recessive mutations in the mouse.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital and Department of Medical Genetics, University of Toronto, Toronto, Ontario, Canada.
L
L
Lefebvre
N
N
Dionne
J
J
Karaskova
J A
JA
Squire
A
A
Nagy
D000818:Animals; D005260:Female; D018390:Gene Targeting; D005821:Genetic Techniques; D006720:Homozygote; D019868:Kanamycin Kinase / Q000235:genetics; D019656:Loss of Heterozygosity; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D016296:Mutagenesis; D013234:Stem Cells / Q000378:metabolism*
D019868:Kanamycin Kinase